The number of robotic surgery for gastroenterological malignant diseases performed using the da Vinci Surgical System (DVSS) has been rapidly increasing in Japan, after approval for national medical insurance coverage in April 2018. Various regulations and systems to safely introduce robotic surgery, including the latest guideline for robotic surgery from the Japan Society for Endoscopic Surgery, institution criteria, registry system, and proctor certification system have been developed. Accordingly, reports about robotic surgery for upper gastrointestinal cancer from Japan have also been increasing, and they suggest that robotic gastrectomy can possibly reduce the incidence of morbidities. There are still several problems such as cost and restriction of operators or facilities. However, a novel surgical robot, the hinotori™ Surgical Robot System, have been developed, the promising project to realize the practical use of telesurgery is undergoing. We believe that further progression of medical technology would enable surgeons to perform robotic surgery more comfortably and safely and would consequently help in achieving less invasive surgery.
View full abstract